FMCの空売り状況は、投資家がFMCの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

FMC (NYSE:FMC) 株価情報, 空売り情報

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Large Cap

Macro Notification

Mid Cap

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Rumors

Commodities

Small Cap

Treasuries

Econ #s

Federal Reserve

Tech

ETFs

$BTC

AAPL

AFRM

SPDR Dow Jones Industrial Average ETF Trust

ダウ工業株30種平均は0.7％低下し、19,076.80ポイント、S&amp;P 500 は5,348.59ドル（0.2％減）となり、ナスダック総合株価指数は38,578.53ドル（0.7％減）で推移しています。

アップルが史上最高値を更新もビットコインは停滞

FMC Corp

FRMRS&MER BNCORP LODI CA by Farmers & Merchants Bancorp

Farmers & Merchants Bancorp

Federal Home Loan Mortgage Corp

Northern Lights Fund Trust IV FM Compounders Equity ETF

FRESENIUS MED CARE AG ORD by Fresenius Medical Care AG

Fresenius Medical Care AG

FM Focus Equity ETF

FORAN MINING CORP by Foran Mining Corporation

Foran Mining Corp

8 analysts have expressed a variety of opinions on FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $65.5, a high estimate of $81.00, and a low estimate of $55.00. Experiencing a 8.12% decline, the current average is now lower than the previous average price target of $71.29. 
<img src="https://www.benzinga.com/files/images/story/2025/1736877660_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive FMC. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$61.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Christopher Parkinson</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$69.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$66.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Christopher Parkinson</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$81.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$67.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to FMC. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for FMC's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of FMC's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on FMC analyst ratings.</a>
<h2>Unveiling the Story Behind FMC</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>FMC's Financial Performance</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: FMC's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 8.5%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 6.08%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): FMC's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 1.41%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.53%, the company showcases effective utilization of assets.
Debt Management: FMC's debt-to-equity ratio surpasses industry norms, standing at 0.88. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Demystifying FMC: Insights From 8 Analyst Reviews

The chemical industry could be in for a turbulent 2025 spurred by increased demand, cost inflation and President-elect <a href="https://www.benzinga.com/markets/commodities/24/11/42235640/trumps-energy-policies-poised-to-reshape-oil-gas-market-winners-and-losers-revealed">Donald Trump&#8216;s PFAS policies</a>.
The Chemicals Analyst: Bank of America analyst Steve Byrne released a note covering the chemicals industry on Tuesday, upgrading and downgrading several companies:
<ul>
<li>Archer-Daniels-Midland Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) from Neutral to Underperform, lowering its price target from $63 to $54.</li>
<li>Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Underperform to Buy, lowering its price target from $95 to $88.</li>
<li>Eastman Chemical Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) from Neutral to Buy, lowering its price target from $115 to $109.</li>
<li>Element Solutions Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESI#NYSE">ESI</a>) from Buy to Neutral, lowering its price target from $32 to $28.</li>
<li>FMC Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Underperform to Neutral, lowering its price target from $63 to $61.</li>
<li>Olin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) from Neutral to Buy, lowering its price target from $48 to $40.</li>
<li>Origin Materials Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGN#NASDAQ">ORGN</a>) from Buy to Underperform, lowering its price target from $2.50 to $1.50.</li>
</ul>
Main Takeaways: Agriculture stocks faced a decline in the waning months of 2024, amid market concerns over potential trade policies under President-elect Trump and the impact of rising interest rates linked to the federal deficit. Byrne believes the market has already re-priced higher risk.
The analyst believes chemicals will see increased demand with a caveat.
&#8220;We expect end-market demand to grow this year, although we&#8217;ve pared back expectations, given incremental headwinds from tariff concerns, a strong USD, and higher interest rate expectations, among others,&#8221; Byrne said. &#8220;Still, the U.S. Manufacturing PMI has been surprisingly weak and the risk-reward is skewed positively in our view.&#8221;
Meanwhile, the analyst foresees a return of inflationary pressures on input costs, squeezing margins.
Byrne says Trump&#8217;s election win and a possible &#8220;trade war&#8221; could slow GDP growth and hurt chemical companies&#8217; bottom lines. He notes deregulation and lower corporate taxes as a positive. The analyst suggests that Trump&#8217;s weakening of the EPA could pause certain regulatory initiatives, potentially increasing litigation risks for PFAS manufacturers.
Company Takeaways: Byrne cited declining profitability and increased macroeconomic risk for his Archer-Daniels-Midland downgrade.
The analyst upgraded Celanese&#8217;s stock based on an expected demand recovery, an attractive valuation and potential benefits from shareholder activism.
Eastman Chemical took a severe hit in 2024&#8217;s fourth quarter. Byrne says the market&#8217;s sell-off was &#8220;overdone&#8221; and is optimistic for future revenue and earnings growth.
Byrne downgraded Element Solutions and said there is better opportunity elsewhere. He noted possible currency headwinds.
FMC could face a tough recovery from its struggles in 2024, but Byrne is optimistic that the company&#8217;s EBITDA can rebound. The analyst says market multiples are &#8220;appropriately reflecting risks.&#8221;
Byrne says Olin&#8217;s valuation is &#8220;highly attractive&#8221; due to its high free cash flow yield. The analyst also said the company is insulated from Trump administration risks.
The analyst&#8217;s downgrade of Origin Materials is linked to doubts that the company will be able to license its technology and possible headwinds for sustainable products.
Price Action: Several of the companies showed sharp movement following the analyst&#8217;s note:
<ul>
<li>Archer-Daniels-Midland traded at $51.18, down 1.8%.</li>
<li>Celanese Corporation traded at $71.97, up 6.81%.</li>
<li>Eastman Chemical traded at $91.77, up 2.99%.</li>
<li>FMC Corp traded at $53.16, up 2.17%.</li>
<li>Olin Corp traded at $33.10, up 4.38%.</li>
<li>Origin Materials traded at $1, down 9.9%.</li>
</ul>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42974739/wall-street-rebounds-as-producer-inflation-misses-estimates-tesla-gains-chinese-stocks-rally">Wall Street Rebounds As Producer Inflation Misses Estimates, Tesla Gains, Chinese Stocks Rally</a></li>
</ul>
Photo: dongfang/Shutterstock.com

Analyst Color

Government

Regulations

Upgrades

Downgrades

Price Target

Economics

ORGN

Increased Demand, Trump Administration Risks: Analyst Picks Celanese As Chemical Winner, ADM As Loser For 2025

B of A Securities analyst Steve Byrne upgrades FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Underperform to Neutral and lowers the price target from $63 to $61.

News

B of A Securities Upgrades FMC to Neutral, Lowers Price Target to $61

Mizuho analyst Christopher Parkinson maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral and lowers the price target from $70 to $55.

Mizuho Maintains Neutral on FMC, Lowers Price Target to $55

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>JMP Securities raised the price target for Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) from $660 to $750. JMP Securities analyst Matthew Condon maintained a Market Outperform rating. Meta shares closed at $585.51 on Tuesday. <a href="https://www.benzinga.com/quote/META/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan cut Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) price target from $55 to $48. JP Morgan analyst Arun Jayaram maintained an Overweight rating. SLB shares closed at $38.34 on Tuesday. See how other analysts view this stock.</li>
<li>Deutsche Bank cut the price target for Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) from $611 to $523. Deutsche Bank analyst Scott Deuschle downgraded the stock from Buy to Hold. Lockheed Martin shares closed at $485.94 on Tuesday. <a href="https://www.benzinga.com/quote/LMT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo raised the price target for CyberArk Software Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) from $350 to $410. Wells Fargo analyst Andrew Nowinski maintained an Overweight rating. CyberArk Software shares closed at $333.15 on Tuesday. See how other analysts view this stock.</li>
<li>Keybanc cut FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) price target from $79 to $69. Keybanc analyst Aleksey Yefremov maintained an Overweight rating. FMC shares settled at $48.61 on Tuesday. <a href="https://www.benzinga.com/quote/FMC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Northland Capital Markets increased Astera Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) price target from $100 to $120. Northland Capital Markets analyst Gus Richard downgraded the stock from Outperform to Market Perform. Astera Labs shares closed at $132.45 on Tuesday. <a href="https://www.benzinga.com/quote/ALAB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank cut Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) price target from $611 to $523. Deutsche Bank analyst Scott Deuschle downgraded the stock from Buy to Hold. Lockheed Martin shares closed at $485.94 on Tuesday.  <a href="https://www.benzinga.com/quote/LMT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan slashed the price target for Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) from $55 to $48. JP Morgan analyst Arun Jayaram maintained an Overweight rating. SLB shares settled at $38.34 on Tuesday. <a href="https://www.benzinga.com/quote/SLB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer cut Universal Display Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLED#NASDAQ">OLED</a>) price target from $220 to $200. Oppenheimer analyst Martin Yang maintained an Outperform rating. Universal Display shares closed at $146.20 on Tuesday. <a href="https://www.benzinga.com/quote/OLED/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank increased The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) price target from $184 to $215. Deutsche Bank analyst Scott Deuschle maintained a Buy rating. Boeing shares closed at $177.00 on Tuesday. <a href="https://www.benzinga.com/quote/BA/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42763645/how-to-earn-500-a-month-from-acuity-brands-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Acuity Brands Stock Ahead Of Q1 Earnings</a></li>
</ul>

Markets

Trading Ideas

ALAB

CYBR

OLED

Meta To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday

Keybanc analyst Aleksey Yefremov maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Overweight and lowers the price target from $79 to $69.

Keybanc Maintains Overweight on FMC, Lowers Price Target to $69

UBS analyst Joshua Spector maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Buy and lowers the price target from $75 to $66.

UBS Maintains Buy on FMC, Lowers Price Target to $66

4 analysts have shared their evaluations of FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated FMC and provided 12-month price targets. The average target is $68.25, accompanied by a high estimate of $81.00 and a low estimate of $55.00. This current average has decreased by 3.42% from the previous average price target of $70.67. 
<img src="https://www.benzinga.com/files/images/story/2024/1734552043_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive FMC. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Christopher Parkinson</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$81.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$67.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FMC. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into FMC's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on FMC analyst ratings.</a>
<h2>About FMC</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>FMC's Financial Performance</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: FMC's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 8.5%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: FMC's net margin is impressive, surpassing industry averages. With a net margin of 6.08%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): FMC's ROE stands out, surpassing industry averages. With an impressive ROE of 1.41%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): FMC's ROA excels beyond industry benchmarks, reaching 0.53%. This signifies efficient management of assets and strong financial health.
Debt Management: FMC's debt-to-equity ratio surpasses industry norms, standing at 0.88. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 4 Analyst Projections For FMC

Citigroup analyst Patrick Cunningham maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral and lowers the price target from $70 to $55.

Citigroup Maintains Neutral on FMC, Lowers Price Target to $55

Mizuho analyst Christopher Parkinson maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral and raises the price target from $64 to $70.

Mizuho Maintains Neutral on FMC, Raises Price Target to $70

RBC Capital analyst Arun Viswanathan maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Outperform and raises the price target from $78 to $81.

RBC Capital Maintains Outperform on FMC, Raises Price Target to $81

WIIM

FMC shares are trading higher after the company reported better-than-expected Q3 financial results.

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday.
Shares of Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) gained 13.5% to $12.38 following better-than-expected <a href="https://www.benzinga.com/news/earnings/24/10/41627569/snap-stock-is-surging-today-whats-going-on">quarterly financial results.</a>
Snap reported third-quarter revenue of $1.373 billion, beating the consensus estimate of $1.358 billion, according to Benzinga Pro. The social media company reported adjusted earnings of 8 cents per share, beating analyst estimates of 5 cents per share.
Snap shares jumped 13.5% to $12.38 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) shares jumped 41.3% to $115.48 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates.</li>
<li>Omnicell, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMCL#NASDAQ">OMCL</a>) gained 37% to $54.99 after the company reported better-than-expected third-quarter financial results and raised its FY24 guidance above estimates.</li>
<li>Unisys Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UIS#NYSE">UIS</a>) surged 30.7% to $7.03 after the company reported better-than-expected third-quarter sales results and raised its FY24 non-GAAP operating profit margin guidance.</li>
<li>ASP Isotopes Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPI#NASDAQ">ASPI</a>) rose 30.7% to $7.53 after the company announced that it has entered into a term sheet with TerraPower for the construction of a HALEU production facility.</li>
<li>NerdWallet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRDS#NASDAQ">NRDS</a>) gained 27.3% to $14.41 after the company reported better-than-expected quarterly revenue results.</li>
<li>AtriCure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRC#NASDAQ">ATRC</a>) surged 23% to $36.21 after the company reported better-than-expected third-quarter financial results and issued FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $34 to $40.</li>
<li>Garmin Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRMN#NASDAQ">GRMN</a>) gained 22.9% to $204.48 after the company reported better-than-expected third-quarter financial results and raised annual outlook.</li>
<li>Exelixis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) surged 14.6% to $32.92 after the company reported better-than-expected quarterly financial results and raised its FY24 sales guidance above estimates.</li>
<li>The Cheesecake Factory Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAKE#NASDAQ">CAKE</a>) gained 13.6% to $48.69 after the company reported better-than-expected quarterly adjusted EPS results. Also, multiple firms raised their respective price targets on the stock.</li>
<li>Adtalem Global Education Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGE#NASDAQ">ATGE</a>) rose 12.7% to $84.53 following first-quarter results.</li>
<li>FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) gained 11.5% to $67.12 following better-than-expected quarterly earnings.</li>
<li>OneMain Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMF#NYSE">OMF</a>) rose 10.8% to $52.63 following strong quarterly earnings.</li>
<li>Smurfit Westrock Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>) gained 10.4% to $49.38 following third-quarter results.</li>
<li>Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) surged 6.2% to $129.21.</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) gained 5.3% to $180.25 following better-than-expected third-quarter earnings.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41623120/jim-cramer-says-buy-crowdstrike-stock-calls-this-aerospace-manufacturer-is-a-high-specul">Jim Cramer Says Buy CrowdStrike Stock, Calls This Aerospace Manufacturer A &#8216;High Speculative&#8217; Stock</a></li>
</ul>

Intraday Update

Movers

ASPI

Adtalem Global Education Inc. Common Stock

ATGE

ATRC

CAKE

DELL

EXEL

GOOG

GRMN

NRDS

OMCL

RDDT

SNAP

Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday

Guidance

FMC Sees FY24 Adj. EPS $3.16-$3.52 vs $3.28 Est., Revenue $4.33B-$4.44B vs $4.364B Est.

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.53 by 30.19 percent. The company reported quarterly sales of $1.070 billion which beat the analyst consensus estimate of $1.036 billion by 3.32 percent. This is a 8.97 percent increase over sales of $981.900 million the same period last year.

Earnings

Earnings Beats

FMC Q3 2024 Adj. EPS $0.69 Beats $0.53 Estimate, Sales $1.070B Beat $1.036B Estimate

Ratings for FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $67.0, along with a high estimate of $79.00 and a low estimate of $59.00. This upward trend is evident, with the current average reflecting a 5.93% increase from the previous average price target of $63.25.
<img src="https://www.benzinga.com/files/images/story/2024/1729702841_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive FMC. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$67.00</td>
<td>-</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$59.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$65.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Joel Jackson</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$65.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$79.00</td>
<td>$81.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FMC. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into FMC's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on FMC analyst ratings.</a>
<h2>Get to Know FMC Better</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>Financial Milestones: FMC's Journey</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Positive Revenue Trend: Examining FMC's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 2.36% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: FMC's net margin excels beyond industry benchmarks, reaching 28.33%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): FMC's ROE stands out, surpassing industry averages. With an impressive ROE of 6.63%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): FMC's ROA stands out, surpassing industry averages. With an impressive ROA of 2.44%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: FMC's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.92, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Key Takeaways From FMC Analyst Ratings

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>B. Riley Securities analyst Hal Goetsch initiated coverage on Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) with a Neutral rating and announced a price target of $185. Coinbase shares closed at $210.72 on Tuesday. <a href="https://www.benzinga.com/quote/COIN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>CLSA initiated coverage on Charles River Laboratories International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRL#NYSE">CRL</a>) with an Underperform rating and announced a price target of $167. Charles River shares closed at $185.94 on Tuesday. <a href="https://www.benzinga.com/quote/CRL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Patrick Cunningham initiated coverage on FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral rating and announced a price target of $67. FMC shares closed at $62.38 on Tuesday. <a href="https://www.benzinga.com/quote/FMC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Daiwa Capital initiates coverage on Grab Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) with an Outperform rating and announced a price target of $4.6. Grab shares closed at $4.16 on Tuesday. <a href="https://www.benzinga.com/quote/GRAB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer initiated coverage on Ferguson Enterprises Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>) with an Outperform rating and announced a price target of $234. Ferguson shares closed at $195.99 on Tuesday. <a href="https://www.benzinga.com/quote/FERG/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Read More:<a href="https://www.benzinga.com/news/earnings/24/10/41479244/dow-edges-lower-as-investors-watch-earnings-reports-with-caution-fear-index-remains-in-greed-zone"> </a>
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41479244/dow-edges-lower-as-investors-watch-earnings-reports-with-caution-fear-index-remains-in-greed-zone">Dow Edges Lower As Investors Watch Earnings Reports With Caution: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Initiation

Pre-Market Outlook

COIN

FERG

GRAB

This Ferguson Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for FMC, presenting an average target of $67.0, a high estimate of $79.00, and a low estimate of $59.00. This upward trend is evident, with the current average reflecting a 5.93% increase from the previous average price target of $63.25.
<img src="https://www.benzinga.com/files/images/story/2024/1729684872_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A clear picture of FMC's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$67.00</td>
<td>-</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$59.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$65.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Joel Jackson</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$65.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$79.00</td>
<td>$81.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FMC. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into FMC's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on FMC analyst ratings.</a>
<h2>About FMC</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>Unraveling the Financial Story of FMC</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: FMC's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 2.36%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: FMC's net margin excels beyond industry benchmarks, reaching 28.33%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): FMC's ROE excels beyond industry benchmarks, reaching 6.63%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): FMC's ROA excels beyond industry benchmarks, reaching 2.44%. This signifies efficient management of assets and strong financial health.
Debt Management: FMC's debt-to-equity ratio surpasses industry norms, standing at 0.92. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>What Are Analyst Ratings?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FMC Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

Citigroup analyst Patrick Cunningham initiates coverage on FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral rating and announces Price Target of $67.

Citigroup Initiates Coverage On FMC with Neutral Rating, Announces Price Target of $67

FMC Corporation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) stock looks promising at the moment. It benefits from efforts to expand its product portfolio through new product launches and its restructuring actions.
Let&#39;s see what makes FMC stock a compelling investment option at the moment.
<h2>FMC Stock Outperforms Industry</h2>
FMC has outperformed the industry it belongs to over the past three months. The company&#39;s shares have gained 13.8% compared with a 7.7% rise of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/c7/80480.jpg?v=1918707670" />
Image Source: Zacks Investment Research
<h2>FMC&#39;s Valuation Looks Attractive</h2>
FMC&#39;s attractive valuation should lure investors seeking value. The stock is currently trading at a forward 12-month earnings multiple of 14.52X, representing a roughly 12.4% discount when stacked up with the industry average of 16.58X. FMC also has a Value Score of B.
<h2>FMC&#39;s Earnings Estimates Going Up</h2>
Earnings estimates for FMC have been going up over the past 60 days. The Zacks Consensus Estimate for 2024 has increased by 0.6%. The consensus estimate for 2025 has also been revised 3.5% upward over the same time frame.
<h2>New Products, Restructuring Actions Aid FMC Stock</h2>
FMC remains focused on strengthening its product portfolio. It is investing in technologies as well as new product launches to enhance value to the farmers. New products launched in Europe, North America and Asia are gaining significant traction. Product introductions are expected to support the company&#39;s results this year.
FMC generated $590 million in sales in 2023 from new products launched in the past five years. It expects revenues from new products to grow by roughly $200 million in 2024. It expects a significant amount of volume growth to come from new products in the second half of 2024. FMC is seeing strong gains in new products including Coragen eVo and Premio Star insecticides and the Onsuva fungicide in Latin America.
The acquisition of BioPhero ApS, a Denmark-based pheromone research and production company, also adds biologically produced state-of-the-art pheromone insect control technology to the company&#39;s product portfolio and R&amp;D pipeline, highlighting FMC&#39;s role as a leader in delivering innovative and sustainable crop protection solutions.
The company is also expected to benefit from reduced input costs, favorable product mix and its cost-control actions. It benefited from favorable input costs in the second quarter of 2024. FMC is also making progress with its global restructuring and cost-reduction program. It sees benefits from restructuring to contribute $75-$100 million to full-year 2024 adjusted EBITDA, net of inflation.
<div class="chart_embed">
<h3>FMC Corporation Price and Consensus</h3>
<img alt="FMC Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/17/1728291628.png" style="height:265px; width:576px" title="" />
FMC Corporation price-consensus-chart | FMC Corporation Quote
</div>
<h2>FMC&#39;s Zacks Rank &amp; Other Key Picks</h2>
FMC currently carries a Zacks Rank #2 (Buy).
Other top-ranked stocks in the Basic Materials space are IAMGOLD Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iag#NYSE">IAG</a>), Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>) and Axalta Coating Systems Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axta#NYSE">AXTA</a>). While IAMGOLD sports a Zacks Rank #1 (Strong Buy), Cabot and Axalta Coating carry a Zacks Rank #2.
The Zacks Consensus Estimate for IAMGOLD&#39;s current-year earnings has increased by 45.4% in the past 60 days. IAG beat the consensus estimate in each of the last four quarters with the average surprise being 200%. Its shares have shot up roughly 132% in the past year.
The consensus estimate for Cabot&#39;s current fiscal year earnings is pegged at $7.07 per share, indicating a year-over-year rise of 31.4%. The consensus estimates for CBT&#39;s current-year earnings has increased by 4.3% in the past 60 days. The company&#39;s shares have rallied roughly 61% in the past year.
The Zacks Consensus Estimate for Axalta Coating&#39;s current year earnings is pegged at $2.07, indicating a rise of 31.9% from year-ago levels. The Zacks Consensus Estimate for AXTA&#39;s current year earnings has increased 2.5% in the past 60 days. The stock has gained around 32% in the past year.
<a href="https://www.zacks.com/stock/news/2346902/here-s-why-you-should-add-fmc-stock-to-your-portfolio-now?cid=CS-BENZ-FT-analyst_blog|rank_focused-2346902">To read this article on Zacks.com click here.</a>

Penny Stocks

AXTA

Here's Why You Should Add FMC Stock to Your Portfolio Now

In a report released today, Aleksey Yefremov from KeyBanc maintained a Buy rating on FMC (FMC – Research Report), with a price target of $69.00. Th...

KeyBanc Remains a Buy on FMC (FMC)

KeyBanc lowered the firm's price target on FMC Corporation (FMC) to $69 from $79 and keeps an Overweight rating on the shares. With FMC shares maki...

FMC Corporation price target lowered to $69 from $79 at KeyBanc

Jefferies analyst Laurence Alexander has maintained their bullish stance on FMC stock, giving a Buy rating today. Laurence Alexander's rating is ba...

FMC's Innovative Strategies and Market Positioning Justify Buy Rating Despite Short-term Challenges

The S&P 500's 10 worst-performing stocks in 2023 fell again in 2024

Mizuho lowered the firm's price target on FMC (FMC) to $55 from $70 and keeps a Neutral rating on the shares. In conjunction with its 2025 outlook ...

FMC price target lowered to $55 from $70 at Mizuho

Wells Fargo's Harvey: Investors could be driving pricing strategy in stocks

BofA upgraded FMC (FMC) to Neutral from Underperform with a price target of $61, down from $63. Published first on TheFly – the ultimate source for...

FMC upgraded to Neutral from Underperform at BofA

As previously reported, BofA analyst Steve Byrne upgraded FMC (FMC) to Neutral from Underperform with a price target of $61, down from $63. While t...

FMC upgraded to Neutral at BofA with growth headwinds priced in

Eastman Chemical, Olin, Celanese, FMC upgraded at Bank of America

Bets against S&P 500 materials stocks jump in December, International Paper most shorted

ALLE

AMCR

CTVA

ENPH

ETSY

MDLZ

MRNA

PAYC

UPRO

Press Releases

FMC Corporation submits regulatory applications in eight countries for Dodhylex™ active

FMC Corporation granted a temporary restraining order against Sharda USA LLC for patent infringement in the United States

FMC Corporation announces dates for third quarter 2024 earnings release and webcast conference call

FMC Corporation and UN Global Compact Network USA convene global leaders to discuss future of sustainable food systems during United Nations General Assembly

Contracts

FMC Corporation announces distribution agreement with Ballagro Agro Tecnologia Ltda. to expand biologicals crop protection offering in Brazil

FMC Corporation reports strong growth in third quarter, confirms full-year outlook adjusted for expected sale of GSS business

FMC Corporation and Envu complete the sale of FMC's Global Specialty Solutions business

FMC Corporation announces election of Anthony DiSilvestro to Board of Directors

Dividends

FMC Corporation Declares Quarterly Dividend

FMC Corporation announces date for fourth quarter 2024 earnings release and webcast conference call

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions

CF Industries Holdings, Inc. Common Stock

CF Industries Holdings

Corteva

Enlightify

Brazil Potash

Intrepid Potash

Mosaic

N2OFF

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

CVR Partners, LP Common Units representing Limited Partner Interests

Comments

FMC

空売り

FMC (NYSE:FMC) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル